David Frye
Radiation Oncology · Tucson, AZNPI 1750441770
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,791 of the $2,880 with a category attached, or 62.2%. 21 manufacturers reported payments, led by GT Medical Technologies, Inc at 54.6% of the total. 2025 is the largest year on record at $1,791, more than ten times the $61 reported in 2019.
Across 56 payments — averaging $51.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GT Medical Technologies, Inc$2K
- Sumitomo Pharma America, Inc.$254
- Siemens Medical Solutions USA, Inc.$145
- Regeneron Healthcare Solutions, Inc.$123
- Merck$91
- Amgen$85
- plus $612 from 15 others
What the payments were for
- Travel & lodging$1,09038%
- Food & beverage$1,79162%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GT Medical Technologies, Inc | 6 | $1,572 |
| Sumitomo Pharma America, Inc. | 6 | $254 |
| Siemens Medical Solutions USA, Inc. | 1 | $145 |
| Regeneron Healthcare Solutions, Inc. | 4 | $123 |
| Merck | 6 | $91 |
| Amgen | 5 | $85 |
| Novocure Inc. | 4 | $83 |
| AbbVie | 3 | $78 |
| Daiichi Sankyo Inc. | 3 | $76 |
| Bayer | 4 | $70 |
| Johnson & Johnson | 2 | $57 |
| Genentech USA, Inc. | 2 | $41 |
| Blueprint Medicines Corporation | 2 | $39 |
| Boehringer Ingelheim | 1 | $34 |
| Progenics Pharmaceuticals, Inc. | 1 | $28 |
| Myovant Sciences Inc. | 1 | $23 |
| E.r. Squibb & Sons, L.L.C. | 1 | $20 |
| Karyopharm Therapeutics Inc. | 1 | $19 |
| EUSA Pharma (US) LLC | 1 | $15 |
| AstraZeneca | 1 | $15 |
| Lilly USA, LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GammaTile$1,462
- Varian Ethos Treatment Planning$145
- ORGOVYX$135
How this compares
$2,880 in reported general payments places this provider in the 65th percentile of 138 radiation oncology providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tamsulosin Hcl | 37 | $562 |
| Dexamethasone | 11 | $352 |
| Levetiracetam | 16 | $324 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 19 | $305 |
| Memantine Hcl | 19 | $260 |
| Oxycodone Hcl | 18 | $104 |
| Lorazepam | 32 | $56 |
Paid to pharmacies, not to this prescriber.
Other radiation oncology in Tucson
- Baldassarre SteaTucson$10K
- Robert GinTucson$9K
- Curtis MackTucson$8K
- David VonkTucson$6K
- Christopher MorrisonTucson$4K
- Samuel DayTucson$3K
- Reginald WestmacottTucson$3K
- Sarah KilicTucson$2K
- John KreslPhoenix$248K
- Eric GrossChandler$26K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.